Geneva, Switzerland

Claudia Pena Rossi



 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Claudia Pena Rossi: Innovator in Autoimmune Disease Treatment

Introduction

Claudia Pena Rossi is a prominent inventor based in Geneva, Switzerland. She has made significant contributions to the field of immunology, particularly in the treatment of autoimmune diseases. Her innovative approaches have the potential to improve the quality of life for many patients suffering from these conditions.

Latest Patents

Claudia holds a patent for a groundbreaking invention titled "Combination of BLyS and/or APRIL inhibition and immunosuppressants for treatment of autoimmune disease." This invention relates to novel combination therapies that involve BLyS or BLyS/APRIL inhibition alongside immunosuppressants. One preferred method includes the use of Fc-fusion proteins, such as TACI-Fc, BAFF-R-Fc, or BCMA-Fc, which target specific extracellular domains. The methods aim to reduce immunoglobulin levels in patients, providing a new avenue for treating autoimmune diseases.

Career Highlights

Throughout her career, Claudia has worked with notable companies, including Zymogenetics, Inc. and Ares Trading S.A. Her experience in these organizations has allowed her to develop and refine her innovative ideas in the field of immunology.

Collaborations

Claudia has collaborated with esteemed colleagues, including Rafael A Ponce, Jr. and Wayne J Wallis. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Claudia Pena Rossi is a trailblazer in the field of autoimmune disease treatment, with her innovative patent showcasing her dedication to improving patient outcomes. Her work continues to inspire future advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…